Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2016 by University of Pittsburgh
Sponsor:
Collaborator:
Prometheus Laboratories
Information provided by (Responsible Party):
Leonard Appleman, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01550367
First received: February 29, 2012
Last updated: December 22, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: March 2018 (Final data collection date for primary outcome measure)